ArticleJournal of bone oncology2026

Dual-target neoadjuvant therapy with denosumab and sunitinib for giant cell tumor of bone: a sarcoma center experience.

Michal Mahdal et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.